Note I - Stockholders' Equity

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

NOTE I — STOCKHOLDERS’ EQUITY

At the annual shareholders meeting in 2021, the Company received approval to increase its authorized shares of common stock from 85,000,000 to 100,000,000 shares.

WARRANTS

The following table summarizes information about shares issuable under warrants outstanding at December 31, 2022:

	Warrant shares outstanding		Weighted Average exercise price		Weighted Average remaining life		Intrinsic value
Outstanding at January 1, 2022		4,268,221		2.18		1.50		1,187,546
Issued		-		-		-		-
Exercised		-		-		-		-
Outstanding and exercisable at December 31, 2022		4,268,221		2.18		.50		-

SHARES TO BE ISSUED

As of December 31, 2022 and 2021 , there were 2,057,976 and 1,891,979, respectively shares to be issued whose issuance has been deferred under the terms of an employment agreements with the former Interim Chief Executive Officer, former Chief Financial Officer, and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment. 

As of December 31, 2022 and 2021, there were 382,697 and 174,364, respectively shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed at the date of grant and were fully vested upon grant date.

The following table summarizes information about shares to be issue at December 31, 2022 and 2021

	December 31, 2022			December 31, 2021
Shares-to-be-issued, outstanding		2,066,343			2,428,329
Granted in current period		524,814			93,918
Issued in current period		(150,484	)		(455,904	)
Shares-to be issued outstanding		2,440,673			2,066,343